Alkem Laboratories Share Price Today | Stock Price & Alkem Laboratories Share Screener

Track the current stock price of Alkem Laboratories with an interactive chart. Analyse ALKEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Alkem Laboratories stock quote in one place.

The quote of ₹5,015.00 sits between the 52-week low of ₹5,004.00 and the 52-week high of ₹5,890.00, and the latest session moved 0.22% from the previous close.

Screen Alkem Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ALKEM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Basudeo N Singh listed as chairperson or CEO, and it trades under ISIN INE540L01014.

Alkem Laboratories Limited is an Indian pharmaceutical company headquartered in Mumbai, with global operations. The company develops, manufactures, and sells pharmaceutical and nutraceutical products, including branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals. It has a portfolio of over 800 brands in India and operates in more than...more

Classification

Identifiers and Leadership

Screen ALKEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹20,873, up from ₹17,691 in 2025.

Latest statistics put total assets at ₹20,873 and shareholder funds at ₹14,349, with a leverage ratio of 0.13.

Screen Alkem Laboratories income statement and profit fundamentals. Analyze ALKEM quarterly results. Alkem Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹3,803 and net profit was ₹251, equal to earnings per unit of ₹19.77, at an operating margin of 11%.

In that period expenses were ₹3,221, interest cost ₹54 and tax ₹172. The next period listed, 2026-Jun, shows revenue of ₹3,893 and net profit of ₹521.

Screen ALKEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1,963, and net cash flow was an outflow of ₹222.

Over the same period, investing activities used ₹1,682 and financing activities used ₹503.

See Alkem Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Alkem Laboratories promoter holding and ownership changes for ALKEM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 51.20%, foreign institutions 10.16%, domestic institutions 21.40% and the public 17.06%, spread across 62,835 shareholders.

The shareholder count was 62,835 in 2026-Mar, compared with 62,822 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Alkem Laboratories. Alkem Laboratories dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹53.00 per unit for 2026-March, a yield of 1.06%, compared with ₹45.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹53.00, ₹45.00 and ₹40.00 per unit.

See which indices include Alkem Laboratories stock. Check ALKEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 30 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE200.

Get Alkem Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Alkem Laboratories stock events that may affect ALKEM share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 27, 2026, with a record date of August 27, 2026.

It is followed by Extraordinary General Meeting dated August 17, 2026 and Quarterly Result Announcement dated August 14, 2026.

Screen ALKEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen ALKEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 15, 2026.

The next most recent announcements are dated September 24, 2026 and September 23, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 22, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.